These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 2668427

  • 1. Once-daily therapy with ceftriaxone compared with daily multiple-dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind study.
    Mandell LA, Bergeron MG, Ronald AR, Vega C, Harding G, Saginur R, Feld R, Duperval R, Landis SJ, Miedzinski LJ.
    J Infect Dis; 1989 Sep; 160(3):433-41. PubMed ID: 2668427
    [Abstract] [Full Text] [Related]

  • 2. Ceftriaxone compared with cefotaxime for serious bacterial infections.
    Smith CR, Petty BG, Hendrix CW, Kernan WN, Garver PL, Fox K, Beamer A, Carbone K, Threlkeld M, Lietman PS.
    J Infect Dis; 1989 Sep; 160(3):442-7. PubMed ID: 2668428
    [Abstract] [Full Text] [Related]

  • 3. Cefotaxime twice daily versus ceftriaxone once daily. A randomized controlled study in patients with serious infections.
    Simmons BP, Gelfand MS, Grogan J, Craft B.
    Diagn Microbiol Infect Dis; 1995 Sep; 22(1-2):155-7. PubMed ID: 7587031
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the efficacy and adverse effect profile of cefotaxime and ceftriaxone in ICU patients with susceptible infections.
    Thomas P, Daly S, Misan G, Steele T.
    Diagn Microbiol Infect Dis; 1992 Jan; 15(1):89-97. PubMed ID: 1730190
    [Abstract] [Full Text] [Related]

  • 5. Cefotaxime. A pharmacoeconomic review of its use in the treatment of infections.
    Plosker GL, Foster RH, Benfield P.
    Pharmacoeconomics; 1998 Jan; 13(1 Pt 1):91-106. PubMed ID: 10175990
    [Abstract] [Full Text] [Related]

  • 6. Treatment of lower respiratory tract infections with ceftriaxone and cefotaxime. A comparative study.
    Abbate GF, Alagia I, Giaquinto E, Leonessa V, Savioli L, Altucci P, Caputi M, Guarino C, Micillo E, Catena E.
    Respiration; 1986 Jan; 49(3):222-30. PubMed ID: 3515468
    [Abstract] [Full Text] [Related]

  • 7. Ceftriaxone once daily compared with four daily doses of cefotaxime in the treatment of severe gram-negative septicemia or pyemia: a randomized study.
    Leu HS, Lasserre R.
    Changgeng Yi Xue Za Zhi; 1995 Mar; 18(1):36-42. PubMed ID: 7767852
    [Abstract] [Full Text] [Related]

  • 8. Outcome of a ceftriaxone/cefotaxime interchange programme in a major teaching hospital.
    Gutensohn A, Bunz D, Frighetto L, Jewesson P.
    Chemotherapy; 1991 Mar; 37 Suppl 3():15-21. PubMed ID: 1909228
    [Abstract] [Full Text] [Related]

  • 9. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
    Wells WG, Woods GL, Jiang Q, Gesser RM.
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185
    [Abstract] [Full Text] [Related]

  • 10. [Comparative study of intravenous ceftriaxone followed by oral cefixime versus ceftriaxone alone in the treatment of severe upper urinary tract infections].
    Regnier B.
    Presse Med; 1989 Oct 11; 18(32):1617-21. PubMed ID: 2530546
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen.
    Bradsher RW, Snow RM.
    Am J Med; 1984 Oct 19; 77(4C):63-7. PubMed ID: 6093522
    [Abstract] [Full Text] [Related]

  • 13. Single-dose ceftriaxone versus multi-dose cefotaxime as short-term antimicrobial prophylaxis in urologic surgery. Preliminary results of a multicenter prospective randomized study.
    Periti P, Mazzei T, Lamanna S, Mini E.
    Chemioterapia; 1984 Oct 19; 3(5):295-8. PubMed ID: 6099756
    [Abstract] [Full Text] [Related]

  • 14. Comparison of ceftriaxone with cefotaxime in serious chest infections.
    Reeves JH, Russell GM, Cade JF, McDonald M.
    Chest; 1989 Dec 19; 96(6):1292-7. PubMed ID: 2684552
    [Abstract] [Full Text] [Related]

  • 15. Single-dose prophylaxis of ceftriaxone versus standard dosage of cefotaxime in the prophylaxis of bacterial complications in orthopedic surgery.
    Karachalios T, Lyritis G, Hatzopoulos E, Sapkas G.
    Chemioterapia; 1987 Jun 19; 6(2 Suppl):573-5. PubMed ID: 3334628
    [No Abstract] [Full Text] [Related]

  • 16. Therapy of lower respiratory tract infections: a comparison of ceftriaxone and cefotaxime.
    Barradas P, Zamith M, Videira W, Cardosa T, Marques RA, Avila R.
    Chemotherapy; 1989 Jun 19; 35 Suppl 2():33-40. PubMed ID: 2612238
    [Abstract] [Full Text] [Related]

  • 17. Ceftriaxone therapy of serious bacterial infections in adults.
    Bittner MJ, Dworzack DL, Preheim LC, Tofte RW, Crossley KB.
    Antimicrob Agents Chemother; 1983 Feb 19; 23(2):261-6. PubMed ID: 6301365
    [Abstract] [Full Text] [Related]

  • 18. Clinical and bacteriologic efficacy of ceftriaxone in the United States.
    McCloskey RV.
    Am J Med; 1984 Oct 19; 77(4C):97-103. PubMed ID: 6093528
    [Abstract] [Full Text] [Related]

  • 19. Comparison of ceftriaxone versus cefotaxime for childhood upper urinary tract infections.
    Bakkaloglu A, Saatci U, Soylemezoglu O, Ozen S, Topaloglu R, Besbas N, Saatci I.
    J Chemother; 1996 Feb 19; 8(1):59-62. PubMed ID: 8835111
    [Abstract] [Full Text] [Related]

  • 20. Ceftriaxone for once-a-day therapy of urinary tract infections.
    Childs SJ, Wells WG, Mirelman S.
    Am J Med; 1984 Oct 19; 77(4C):73-6. PubMed ID: 6093524
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.